Author Details

Проценко, Светлана Анатольевна

Issue Section Title File
Vol 16, No 3 (2014) Articles Modern options in personalized therapy of metastatic cutaneous melanoma
Vol 17, No 3 (2015) Articles Osobennosti profilya toksichnosti ingibitorov BRAF i MEK
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Assessment and correction of the geriatric status of patients with metastatic colorectal cancer during the first-line systemic therapy PDF
(Rus)
Vol 23, No 3 (2021) CLINICAL ONCOLOGY Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer PDF
(Rus)
Vol 24, No 2 (2022) CLINICAL ONCOLOGY Current concepts of neuroendocrine cancer of the prostate: a clinical case and review of the literature PDF
(Rus)
Vol 24, No 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
Vol 25, No 3 (2023) CLINICAL ONCOLOGY Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study PDF
(Rus)
Vol 26, No 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)